Can Weight-Loss Drugs Be Fair in Sports? Serena Williams Just Raised the Stakes
An earthquake shook the sporting universe this week: Serena Williams, the 23-time Grand Slam tennis champion, has taken the first step toward a potential comeback by reentering the sport’s anti-doping test pool. After news reports surfaced on Tuesday of her registration with the International Tennis Integrity Agency, Williams tried to quell speculation about a potential […]
New GLP-1 Implant May Help Overweight Pets, Study Underway
By I. Edwards HealthDay ReporterSATURDAY, Dec. 6, 2025 (HealthDay News) — Weight loss drugs aren’t just for people anymore; They may soon be…
Doctors warn ALL fat jab patients there’s one Christmas favourite drink they should avoid at all costs
The festive advice has been given to people using GLP-1 weight-loss medications, such as Mounjaro and Wegovy.
GLP-1 trial seeks to use meds to slim down cats
Obese cats in a clinical trial will be given an implant that slowly releases a GLP-1 over three months.
10 Weekend Reads
The weekend is here! Pour yourself a mug of Danish Blend coffee, grab a seat outside, and get ready for our longer-form weekend reads: • In the Shadow of Jane Street and Citadel Securities, Hudson River Mints Billions: The quiet flash boy has morphed into a powerhouse among non-bank market makers. (Bloomberg free) • In every corner […]
Chicago food companies like Mush, Farmer’s Fridge flourish as consumers move away from processed foods
A decade ago, Ashley Thompson created the ready-to-eat overnight oats company Mush — a brand that bills itself as a healthier breakfast with nutrient-dense ingredients, free of fillers and additives. The Chicago-based company has sold more than 200 million cups, and its appeal among shoppers caught the attention of its retail partner Whole Foods, who […]
GLP-1 Weight Loss Drugs Have an Unexpected Side Effect
Ed Cara, Gizmodo Every drug has its risks, no matter how tremendous its benefits may be, and sometimes it can take a while to uncover less obvious side effects. New research suggests that…
Food Exec Brief: AI Velocity, GLP-1 Disruption, and Manufacturing’s Autonomous Future
Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering the accelerating deployment of AI across R&D and operations, the seismic impact of GLP-1 medications on consumer behavior, and the convergence of automation and sustainability reshaping competitive dynamics in food and beverage manufacturing. Key takeaways: AI moves from novelty to necessity: Food giants […]
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves
Tempus AI TEM is slowly becoming one of the most vertically integrated data and diagnostics platforms in healthcare, bringing together genomics, multimodal real-world data and clinical AI into a unified system. As its financial performance improves and more FDA-cleared diagnostic tools enter the portfolio, the company is shifting from a heavy investment phase toward a […]
Ozempic on Cats? Updates on Biopharmaceutical Company Launches Pilot Study of GLP-1 Drug in Obese Cats
An Ozempic-like drug implant might be available for your pets soon. Okava Pharma’s GLP-1 implant pilot for obese cats (MEOW-1) aims to combat feline obesity, with due results in 2026.